Endra Life Sciences Inc (NDRA) Stock Price, Quote & News

Company Profile

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 734 335 0468

Website: endrainc.com

Address:

3600 Green Court, Suite 350, Ann Arbor, United States

ZacksResearch Oct. 24 at 2:00 PM

$NDRA is up 4% in premarket trading 🚀 💰 NDRA closed its $4.9M PIPE financing, led by institutional and crypto investors, with potential for an additional $9.5M via warrants. 🌐 The company also launched its Digital Asset Treasury (DAT) strategy, acquiring ~78.9K HYPE tokens (~$3M) — a top Arca DeFi holding. ⚡ CEO Alexander Tokman calls it a “foundational step” in deploying capital into innovative, yield-generating digital ecosystems — blending biotech innovation with Web3 finance. Check out the latest for the stock here. https://www.zacks.com/stock/quote/NDRA?q=NDRA&cid=sm-stocktwits-0-quote_overview-oc-17450&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_17450

0 · Reply

drwaz Oct. 24 at 10:53 AM

$NDRA 👀

0 · Reply

_www_larval_com_ Oct. 23 at 7:07 PM

$NDRA has reverted 4% higher to -3% (~947Kv) moments ago, follow for more volatility.

0 · Reply

VMAESA Oct. 23 at 2:51 PM

Stop✋ looking at those pointless “alerts” when your clueless furu’s cant show you results like these👇 Follow & use the link in bio to join the BEST community on this planet🥳 $AREB $NDRA $GNPX $VTYX $SLMT

0 · Reply

dndodd Oct. 23 at 1:47 PM

$NDRA getting into crypto tokens called HYPE. unbelievable.

0 · Reply

VMAESA Oct. 23 at 12:41 PM

$NITO $NDRA Quick morning shorts

0 · Reply

tradeXLNC Oct. 23 at 12:30 PM

#xlnc #scanner ☀️Good morning folks, some runners that hit our scanner today in the premarket session – $NDRA $SCNX $NITO

1 · Reply

Jesus222 Oct. 23 at 12:06 PM

$NDRA first thing i thought. treasury amount is small as hell as well. probably pumping to get inst investors out

0 · Reply

MahiMe Oct. 23 at 12:05 PM

$NDRA $NDRA ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings https://www.stocktitan.net/news/NDRA/endra-life-sciences-closes-up-to-14-4-million-private-placement-and-blstcceuy6ij.html

0 · Reply

BullsEye2000 Oct. 23 at 12:03 PM

$NDRA personally I don’t think a $15 mill pipe is going to make this run much. Staying out

0 · Reply

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Oct 13, 2025, 8:00 AM EDT - 12 days ago

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

Aug 14, 2025, 4:05 PM EDT - 2 months ago

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

Jun 16, 2025, 8:00 AM EDT - 4 months ago

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

May 15, 2025, 4:05 PM EDT - 5 months ago

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

Mar 31, 2025, 8:05 AM EDT - 7 months ago

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Mar 31, 2025, 8:00 AM EDT - 7 months ago

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

Nov 22, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nov 15, 2024, 9:24 AM EST - 1 year ago

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

Nov 6, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

Oct 22, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Aug 30, 2024, 8:54 AM EDT - 1 year ago

Data I/O And 2 Other Stocks Under $5 Executives Are Buying

DAIO

Aug 28, 2024, 4:17 PM EDT - 1 year ago

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Aug 22, 2024, 5:54 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 4:14 PM EDT - 1 year ago

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 16, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Reverse Stock Split

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

Aug 13, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Leadership Changes

Aug 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

Jun 4, 2024, 9:21 AM EDT - 1 year ago

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

Jun 4, 2024, 9:06 AM EDT - 1 year ago

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

May 20, 2024, 8:00 AM EDT - 1 year ago

ENDRA Provides Update Following In-person Meeting with FDA

May 14, 2024, 8:30 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

May 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

May 2, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

Mar 28, 2024, 9:10 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 21, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

Feb 27, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Installs First TAEUS System in the UK

Feb 21, 2024, 8:00 AM EST - 1 year ago

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

Feb 14, 2024, 8:30 AM EST - 1 year ago

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Nov 29, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Nov 27, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference

Nov 14, 2023, 10:14 PM EST - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 2 years ago

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

Nov 7, 2023, 4:05 PM EST - 2 years ago

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

Nov 6, 2023, 8:00 AM EST - 2 years ago

ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023

Sep 7, 2023, 8:00 AM EDT - 2 years ago

Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

Aug 30, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

Aug 23, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

Aug 14, 2023, 9:44 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

Aug 14, 2023, 1:30 PM EDT - 2 years ago

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

Aug 1, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

Jul 6, 2023, 4:45 PM EDT - 2 years ago

ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023

Jun 7, 2023, 8:00 AM EDT - 2 years ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

May 15, 2023, 9:48 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript

ZacksResearch Oct. 24 at 2:00 PM

0 · Reply

drwaz Oct. 24 at 10:53 AM

$NDRA 👀

0 · Reply

_www_larval_com_ Oct. 23 at 7:07 PM

$NDRA has reverted 4% higher to -3% (~947Kv) moments ago, follow for more volatility.

0 · Reply

VMAESA Oct. 23 at 2:51 PM

0 · Reply

dndodd Oct. 23 at 1:47 PM

$NDRA getting into crypto tokens called HYPE. unbelievable.

0 · Reply

VMAESA Oct. 23 at 12:41 PM

$NITO $NDRA Quick morning shorts

0 · Reply

tradeXLNC Oct. 23 at 12:30 PM

#xlnc #scanner ☀️Good morning folks, some runners that hit our scanner today in the premarket session – $NDRA $SCNX $NITO

1 · Reply

Jesus222 Oct. 23 at 12:06 PM

$NDRA first thing i thought. treasury amount is small as hell as well. probably pumping to get inst investors out

0 · Reply

MahiMe Oct. 23 at 12:05 PM

0 · Reply

BullsEye2000 Oct. 23 at 12:03 PM

$NDRA personally I don’t think a $15 mill pipe is going to make this run much. Staying out

0 · Reply

Jesus222 Oct. 23 at 12:03 PM

$NDRA this news feels like a joke lmao

0 · Reply

DekmarTrades Oct. 23 at 12:03 PM

Placement is a three star word and AI voice alerted on my FoxRunner news scanner. This way I am always finding these the second they are released! $NDRA

1 · Reply

DekmarTrades Oct. 23 at 12:01 PM

$NDRA These Private Placement PRs just fly LOL ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

1 · Reply

hirentilala Oct. 22 at 5:08 PM

$NDRA What happened here?

0 · Reply

hirentilala Oct. 22 at 4:52 PM

$NDRA WOW What happened?

0 · Reply

EpicKoala26 Oct. 17 at 1:23 PM

$NDRA Algos do not read stories they read numbers and a 14 target replicated on MarketBeat and StockAnalysis with a timestamped Oct 10 2025 Maxim note is a clean feature for models while 1.41 is the obvious mispricing variable to optimize

0 · Reply

RapidElephant14 Oct. 17 at 1:13 PM

$NDRA The upside comes from volume unlocks. A handful of hospital and clinic partners pushing steady weekly orders can add $100K to $300K quarterly. At 64 to 68 percent GM that stacks quickly. The first multi million annualized guide is when momentum money arrives

0 · Reply

AstroSwings Oct. 17 at 12:05 AM

$NDRA

0 · Reply

dannaho75 Oct. 15 at 4:23 PM

$NDRA 1 on 1s at Maxim Growth Summit are where allocation happens A crisp pitch with 3 pillars market size clinical edge 100 percent 95 percent feasibility and de risked EU launch can convert to 2 to 4 new institutional holders Each marginal buyer tightens spreads and supports higher average daily value https://finance.yahoo.com/news/mainz-biomed-attend-2025-maxim-130100121.html

1 · Reply

R3versalMans Oct. 15 at 4:17 PM

$NDRA Maxim Growth Summit acts like a liquidity event for awareness not just stock volume This team arrives with a CRC asset already registered in the UK and launched in Switzerland plus a second program flashing 100 percent sensitivity 95 percent specificity That is two engines and 1 summit

0 · Reply

Estebanvel Oct. 15 at 3:00 PM

$NDRA Any chance to get back to 10?

0 · Reply

BlazerD Oct. 15 at 2:11 PM

$NDRA you guys think it'll make it back to my break even price??

1 · Reply

Market Cap	3.73M
Revenue (ttm)	0.00
Net Income (ttm)	-11.51M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	49,700
Avg Vol	339,154
Day's Range	N/A - N/A
Shares Out	753,000.00
Stochastic %K	12%
Beta	-0.09
Analysts	Sell
Price Target	$38.00